Claritev Corporation appointed Ben Letham to its Board of Directors as a Class I director effective September 14, 2026, filling the vacancy created by the passing of John Prince. Letham joins the Risk Committee and brings expertise in artificial intelligence from his role as a research scientist at Meta. This appointment supports the company's strategy to deploy AI across its solutions for healthcare clients. Claritev is a technology, data, and insights company focused on delivering affordability, transparency, and quality across the U.S. healthcare system.
